SARS-CoV-2 and the risk of Parkinson's disease: facts and fantasy
2020; Elsevier BV; Volume: 20; Issue: 2 Linguagem: Inglês
10.1016/s1474-4422(20)30442-7
ISSN1474-4465
AutoresMarcelo Merello, Kailash P. Bhatia, José Á. Obeso,
Tópico(s)Pharmacological Receptor Mechanisms and Effects
ResumoDuring the pandemic it has become clear that severe acure respiratory syndrome coronavirus (SARS-CoV-2) causes not just respiratory disease, but can affect multiple organs and tissues. Of note is the involvement of the CNS and PNS, and the fact that this involvement is independent from the severity of the respiratory disease. Acute and subacute neurological complications of SARS-CoV-2 infections are reported in up to 85% of patients, including those with severe COVID-19, but also in otherwise minimally symptomatic or asymptomatic people.
Referência(s)